FDA Approval Could Turn A Free Drug For A Rare Disease Pricey

Jacobus Pharmaceutical freely gives its experimental drug to patients with a rare disease. Now a rival wants FDA approval to sell its own version — and expects to charge at least $37,500 per year.

—> Read More

facebooktwittergoogle_plusredditpinterestlinkedinmail